News New NICE rules could deny drugs to rare disease patients Patients could be denied treatments, says BIA
News Court bans US sales of Sanofi cholesterol drug Amgen looks to corner PCSK9 market after patent win.
News Sanofi Pasteur and MSD end vaccines joint venture Companies end collaboration after more than 20 years.
News Lilly and Boehringer biosimilar undercuts Lantus by 15% Sanofi under pressure following long-awaited biosimilar launch.
US Vericel hopes for US hit with Maci knee treatment Tissue engineering product previously flopped in EU.
News Sanofi outbids J&J for Actelion merger - reports Reports suggest Sanofi could pay $30 billion for Swiss biotech.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
